MedTrace Logo

Chronic Lymphocytic Leukemia Responds to Dermal Chelation

NCT03495492 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-04-12

No results posted yet for this study

Summary

The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

Conditions

Interventions

DEVICE

Dermal Chelation

Dermal chelation with Aqua DetoxTM system for one or more hours one or more times each week.

DIETARY_SUPPLEMENT

Nutritional Therapy

Vitamins and minerals that will be taken one or more times a day.

Sponsors & Collaborators

  • Optimum Health, Natural Healthcare Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-03-01
Completion
2019-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03495492 on ClinicalTrials.gov